Related Experiment Video
Updated: Dec 4, 2025

Comprehensive Echocardiographic Assessment of Right Ventricle Function in a Rat Model of Pulmonary Arterial Hypertension
Published on: January 20, 2023
Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison
Emilio Nardi1, Giuseppe Mulè1, Antonina Giammanco1
1Dipartimento di Promozione Della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro" (PROMISE), Università Degli Studi di Palermo, Italy.
Insights
Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD) patients, increasing cardiovascular risk. This study found LVH and impaired diastolic function are prevalent in CKD patients, particularly in advanced stages.
Area of Science:
- Nephrology
- Cardiology
- Hypertension
Background:
- Chronic kidney disease (CKD) is associated with increased cardiovascular risk.
- Left ventricular hypertrophy (LVH) is a common complication in CKD patients.
- Understanding LVH prevalence and geometry in CKD is crucial for risk stratification.
Purpose of the Study:
- To determine the prevalence of LVH and left ventricular geometry in hypertensive patients with stage 2-5 CKD.
- To compare LVH and geometry in CKD patients versus essential hypertensive patients with normal renal function.
- To investigate the impact of CKD on diastolic function.
Main Methods:
- Echocardiographic examination of 293 hypertensive patients with stage 2-5 CKD and 289 essential hypertensive patients.
- Exclusion of patients with stage 1 CKD, dialysis, or pre-existing cardiovascular diseases.
- Statistical analysis including multiple regression to assess the association between renal function and LVH.
Main Results:
- LVH was significantly more prevalent in CKD patients (62.8%) compared to essential hypertensives (51.9%).
- Advanced CKD stages showed increased left ventricular dimensions, thickness, and mass.
- Diastolic function was notably worse in CKD patients, especially in later stages.
Conclusions:
- LVH is highly prevalent in CKD patients, often presenting with increased wall thickness and diameter.
- CKD-associated LVH negatively impacts diastolic function.
- Early detection and management of LVH in CKD are essential to mitigate cardiovascular risk.
Background And Aims:
CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function.
Methods And Results:
All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. LVH was observed in 62.8% of patients with CKD and in 51.9% of essential hypertensive patients (P < 0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2-5 CKD. Distribution of concentric and eccentric LVH was not very different between the two groups. However, after introducing mixed hypertrophy, the difference between the two groups group was disclosed (P = 0.027). Multiple regression analysis confirmed that the association between renal function and left ventricular mass (β -0.287; P < 0.0001) was independent by potential confounders. Diastolic function was significantly worse in patients with CKD, especially in more advanced stages.
Conclusion:
Our study confirms that LVH is highly prevalent in patients with CKD, especially by using the most recent cut off; in this population, LVH is often characterized by the simultaneous increase of wall thicknesses and diameters with negative effects on diastolic function.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Pathophysiology of Heart Failure

